Related Experiment Video
Updated: Mar 30, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Genetic testing and genetic counseling in patients with sudden death risk due to heritable arrhythmias
Katherine G Spoonamore1, Stephanie M Ware2
1Department of Medicine, Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, Indiana.
Insights
Genetic testing aids in diagnosing inherited arrhythmias, crucial for preventing sudden cardiac death. This review guides genetic counseling and testing for conditions like long QT syndrome and Brugada syndrome.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Heritable ventricular arrhythmias cause sudden cardiac death, particularly in young individuals.
- Genetic identification of Mendelian arrhythmia diseases informs patient diagnosis and family risk assessment.
- Expanding genetic testing presents opportunities and challenges in clinical management.
Purpose of the Study:
- To review genetic counseling and testing approaches for inherited arrhythmias.
- To highlight genetic principles for specific inherited arrhythmia syndromes.
- To emphasize the role of genetic diagnosis in risk stratification and family management.
Main Methods:
- Literature review of genetic counseling and testing in inherited arrhythmias.
- Summary of genetic principles for long QT syndrome, short QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia.
- Discussion of the integration of genetic information into clinical practice.
Main Results:
- Genetic diagnosis is critical for risk stratification and clinical management of affected families.
- Competency in genetics is needed for effective clinical integration and family-based risk assessment.
- Disease-specific genetic knowledge is essential for accurate genetic testing interpretation and application.
Conclusions:
- Genetic testing and counseling are vital for managing inherited arrhythmias and preventing sudden cardiac death.
- Understanding specific genetic principles is key to utilizing genetic testing effectively.
- Genetic diagnosis empowers comprehensive family-centered care for inherited arrhythmia syndromes.
Abstract:
Sudden cardiac death due to heritable ventricular arrhythmias is an important cause of mortality, especially in young healthy individuals. The identification of the genetic basis of Mendelian diseases associated with arrhythmia has allowed the integration of this information into the diagnosis and clinical management of patients and at-risk family members. The rapid expansion of genetic testing options and the increasing complexity involved in the interpretation of results creates unique opportunities and challenges. There is a need for competency to incorporate genetics into clinical management and to provide appropriate family-based risk assessment and information. In addition, disease-specific genetic knowledge is required to order and correctly interpret and apply genetic testing results. Importantly, genetic diagnosis has a critical role in the risk stratification and clinical management of family members. This review summarizes the approach to genetic counseling and genetic testing for inherited arrhythmias and highlights specific genetic principles that apply to long QT syndrome, short QT syndrome, Brugada syndrome, and catecholaminergic polymorphic ventricular tachycardia.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Dysrhythmias V: Evaluating Dysrhythmias
Pharmacogenomics: Identification of New Drug Targets
Mechanism of Cardiac Arrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

